Healthspring Coverage Criteria
Latest Healthspring coverage criteria updates21
- Coverage CriteriaClinical/Medical PolicyEff. 2026-09-15Spesolimab-sbzo for generalized pustular psoriasisMedical-necessity coverage for spesolimab-sbzo (Spevigo) to treat generalized pustular psoriasis in eligible adults and pediatric patients; self-administered formulations are reviewed under the applicable pharmacy benefit plan.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-07-21Durable Medical Equipment (DME) Reference ListProvides general coverage criteria, eligible and ineligible DME examples, billing guidance, rental or purchase rules, and requirements for repair, replacement, and customized equipment. Providers must also consult the applicable member contract and specific DME medical policies.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-07-21Enzyme Replacement Therapy for Gaucher DiseaseCoverage of imiglucerase, taliglucerase alfa, and velaglucerase alfa for specified Gaucher disease manifestations in adults and pediatric patients, limited to FDA-labeled indications and subject to benefit plan and applicable state requirements.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-07-21Ustekinumab and Associated BiosimilarsThis policy governs coverage of intravenous ustekinumab or an associated biosimilar for Crohn's disease and ulcerative colitis, including age and weight criteria and initial infusion requirements. Self-administered therapy is subject to the applicable pharmacy benefit plan.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Anifrolumab-fniaThis policy governs coverage of anifrolumab-fnia under HealthSpring medical policy, including general medical-policy requirements and a specific Ohio exception for certain off-label uses of FDA-approved drugs.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Aqueous Shunts and Stents for GlaucomaCovers FDA-approved ab externo aqueous shunts and ab interno aqueous stents for glaucoma when medical therapy has failed to adequately control intraocular pressure; certain ab interno stents may be covered with cataract surgery for mild-to-moderate open-angle glaucoma.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Avacincaptad pegolCoverage review for avacincaptad pegol, subject to the member’s benefit plan, applicable state regulations, FDA-approved labeling, recognized clinical evidence, and an Ohio-specific exception for certain recognized off-label uses.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Cerliponase alfaThis policy governs HealthSpring coverage and authorization considerations for cerliponase alfa. Coverage is subject to evidence of effectiveness, authoritative drug-therapy recommendations, applicable state requirements, and the member's benefit contract.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Crovalimab-akkzThis policy governs coverage considerations for crovalimab-akkz and applies to HealthSpring members and their providers. Coverage is subject to the member’s benefit plan or contract, applicable state regulations, and the clinical requirements in the full policy.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Esketamine Nasal SprayThis policy provides HealthSpring guidance for coverage of esketamine nasal spray and directs providers and members to consult the applicable benefit plan, contract, and state regulations. The document window contains general medical-policy standards and an Ohio-specific exception, but no clinical coverage criteria.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Kidney TransplantThis policy governs coverage for living-donor, deceased-donor, and kidney retransplant procedures for carefully selected individuals with end-stage renal disease who meet the policy criteria, subject to the member’s benefit plan and applicable mandates.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Laser Interstitial Tumor Therapy (LITT)This policy governs coverage of magnetic resonance-guided laser interstitial tumor therapy for medically refractory epilepsy, brain tumors, and brain radiation necrosis, and identifies other uses as experimental, investigational, or unproven.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Natalizumab and Associated Biosimilar(s)This policy governs medical-necessity coverage for natalizumab (Tysabri) and natalizumab-sztn (Tyruko) for relapsing multiple sclerosis and moderately to severely active Crohn disease in adults. Other non-FDA-approved indications are considered experimental, investigational, and/or unproven, subject to applicable benefit terms and state requirements.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Teprotumumab-trbw Coverage CriteriaProvides coverage guidance for teprotumumab-trbw, subject to medical-necessity requirements, member benefits, contracts, and applicable state regulations.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Therapeutic Embolization and Vessel Occlusion to Treat Pelvic ConditionsThis policy governs when transcatheter therapeutic embolization or vessel occlusion may be considered medically necessary for selected pelvic conditions, including uterine fibroids, postpartum hemorrhage, symptomatic varicocele, and pelvic congestion syndrome. Coverage is subject to stated clinical criteria and documentation, the member’s benefit plan, and applicable state requirements.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-05-07Treatment of HyperhidrosisThis policy governs medical necessity and coverage determinations for treatments of primary focal and severe secondary gustatory hyperhidrosis, including medically necessary, experimental or unproven, and not medically necessary treatments.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyEff. 2026-01-01Valoctocogene roxaparvovec-rvox (Roctavian) Coverage CriteriaThis policy governs medical-necessity coverage for Roctavian (valoctocogene roxaparvovec-rvox), a gene therapy for adults with severe or moderately severe hemophilia A. Coverage is limited to members meeting all specified clinical, laboratory, infection, and treatment-history criteria; other indications and repeat treatment are considered unproven.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyBurosumab-twzaThis policy governs coverage considerations for burosumab-twza, including the requirement that the requested therapy be proven effective for the diagnosis and that the proposed dose, frequency, and duration align with an authoritative source. Member-specific benefit plans, contracts, and applicable state requirements control when they differ from this policy.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyPozelimab-bbfgHealthSpring coverage of pozelimab-bbfg (Veopoz) for adult and pediatric members age 1 year and older with CD55-deficient protein-losing enteropathy (CHAPLE disease), subject to specified genetic, laboratory, and symptom criteria.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyTriamcinolone Acetonide Extended-Release Injectable Suspension (Zilretta)This policy governs coverage and medical-necessity criteria for Zilretta, an extended-release intra-articular triamcinolone acetonide injection, for HealthSpring members. It covers FDA-approved use for knee osteoarthritis when specified clinical criteria are met and identifies other uses as experimental, investigational, or unproven.All healthspring updates
- Coverage CriteriaClinical/Medical PolicyWheelchairs and AccessoriesThis policy governs coverage and medical necessity criteria for manual and power wheelchairs, power mobility devices, wheelchair options, accessories, batteries, seating, and related equipment for HealthSpring members.All healthspring updates
Tool Description
Search Healthspring coverage criteria and medical necessity requirements across 21,000+ policies from 170+ payers.
Search a drug (“Wegovy”), a procedure (“knee replacement”), or a policy name, then filter by payer, specialty, policy type, or effective year. Or start from the largest publishers: UnitedHealthcare coverage criteria and Cigna coverage criteria.
Each result links the full policy page, which lists the clinical requirements, covered codes, and effective dates from the source document.
Pair a criteria search with the prior authorization lookup for approval requirements, the timely filing lookup for claim deadlines, the live policy updates feed for the newest payer publications, and payer profiles for contacts and coverage context.
FAQ
Coverage Criteria by Payer
Go deeper
Explore OpenPayer Data
Coverage policies are updated every day. Follow payer coverage policy updates in the live policy feed, or browse all CPT, HCPCS and DRG billing codes.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Prior Authorization LookupSearch payer prior authorization policies by drug, procedure, or policy name.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.